Skip to content


Fuzeon (enfuvirtide) is a protein pharmaceutical. Enfuvirtide was first approved as Fuzeon on 2003-03-13. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections.
Trade Name Fuzeon
Common Name Enfuvirtide
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Peptides: antiviral peptides; antivirals
Get full access now